|
C7ORF70 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.4064999999962E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59919999999092E-05 |
| Normal-vs-Stage2 |
3.197400E-03 |
| Normal-vs-Stage3 |
1.514180E-01 |
| Normal-vs-Stage4 |
2.462400E-02 |
| Stage1-vs-Stage2 |
3.327400E-01 |
| Stage1-vs-Stage3 |
7.790000E-02 |
| Stage1-vs-Stage4 |
8.522600E-01 |
| Stage2-vs-Stage3 |
4.871800E-02 |
| Stage2-vs-Stage4 |
3.635600E-01 |
| Stage3-vs-Stage4 |
3.003200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15469999998996E-05 |
| Normal-vs-AfricanAmerican |
1.320200E-01 |
| Normal-vs-Asian |
2.271400E-01 |
| Caucasian-vs-AfricanAmerican |
1.231630E-01 |
| Caucasian-vs-Asian |
6.961600E-01 |
| AfricanAmerican-vs-Asian |
2.860000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.37090000002149E-06 |
| Normal-vs-Female |
1.604040E-02 |
| Male-vs-Female |
2.289900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.390040E-01 |
| Normal-vs-Age(41-60Yrs) |
2.187100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.370860E-04 |
| Normal-vs-Age(81-100Yrs) |
9.867800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.148000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.424000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.804800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.314400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.936200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.971700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.348100E-02 |
| Normal-vs-Grade 2 |
1.67164999999025E-05 |
| Normal-vs-Grade 3 |
9.620400E-03 |
| Normal-vs-Grade 4 |
6.081800E-02 |
| Grade 1-vs-Grade 2 |
3.253600E-01 |
| Grade 1-vs-Grade 3 |
9.120600E-01 |
| Grade 1-vs-Grade 4 |
7.637400E-01 |
| Grade 2-vs-Grade 3 |
1.078040E-01 |
| Grade 2-vs-Grade 4 |
6.635800E-01 |
| Grade 3-vs-Grade 4 |
6.665000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.009300E-04 |
| Normal-vs-ccB subtype |
2.037200E-04 |
| ccA subtype-vs-ccB subtype |
3.326800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.417660E-04 |
| Normal-vs-N1 |
4.287000E-01 |
| N0-vs-N1 |
7.594800E-01 |
|
|
